Tryptophan as a Safe Compound in Topical Ophthalmic Medications:


Journal

Ocular immunology and inflammation
ISSN: 1744-5078
Titre abrégé: Ocul Immunol Inflamm
Pays: England
ID NLM: 9312169

Informations de publication

Date de publication:
19 May 2022
Historique:
pubmed: 23 2 2021
medline: 2 9 2022
entrez: 22 2 2021
Statut: ppublish

Résumé

To evaluate the effects of tryptophan (TRP) on normal human corneal and conjunctival epithelium in vitro and the re-epithelization of corneal erosion in rabbits. Corneal epithelial cell (10.014 pRSV-T) and conjunctival epithelial cell (HC0597) cultures were used. The cellular metabolism, viability, secretion of IL-1β, IL-6, IL-10, cytoskeleton organization, transwell migration were determined. Cells were incubated in the presence of TRP at 1-100 μM. After corneal de-epithelization rabbits received TRP drops (100 μM), 5 times a day. TRP increased conjunctival epithelium metabolism at 50 μM and increased the viability of corneal epithelium at 100 μM. TRP (10 μM) enhanced the production of IL-6 by the corneal epithelium and had no effect on IL-1β and IL-10. TRP had no influence on the cellular cytoskeleton but induced a significant pseudopodia projection in both epithelia. TRP did not influence corneal re-epithelization in vivo. TRP was not toxic for corneal and conjunctival epithelia.

Sections du résumé

BACKGROUND UNASSIGNED
To evaluate the effects of tryptophan (TRP) on normal human corneal and conjunctival epithelium in vitro and the re-epithelization of corneal erosion in rabbits.
MATERIALS AND METHODS UNASSIGNED
Corneal epithelial cell (10.014 pRSV-T) and conjunctival epithelial cell (HC0597) cultures were used. The cellular metabolism, viability, secretion of IL-1β, IL-6, IL-10, cytoskeleton organization, transwell migration were determined. Cells were incubated in the presence of TRP at 1-100 μM. After corneal de-epithelization rabbits received TRP drops (100 μM), 5 times a day.
RESULTS UNASSIGNED
TRP increased conjunctival epithelium metabolism at 50 μM and increased the viability of corneal epithelium at 100 μM. TRP (10 μM) enhanced the production of IL-6 by the corneal epithelium and had no effect on IL-1β and IL-10.
CONCLUSIONS UNASSIGNED
TRP had no influence on the cellular cytoskeleton but induced a significant pseudopodia projection in both epithelia. TRP did not influence corneal re-epithelization in vivo. TRP was not toxic for corneal and conjunctival epithelia.

Identifiants

pubmed: 33616466
doi: 10.1080/09273948.2020.1856883
doi:

Substances chimiques

Interleukin-6 0
Interleukin-10 130068-27-8
Tryptophan 8DUH1N11BX

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

940-950

Auteurs

Anna Matysik-Woźniak (A)

Department of General Ophthalmology, Medical University of Lublin, Lublin, Poland.

Waldemar A Turski (WA)

Department of Experimental and Clinical Pharmacology, Medical University of Lublin, Lublin, Poland.

Monika Turska (M)

Department of Pharmacology, Faculty of Health Sciences, Medical University of Lublin, Lublin, Poland.
School of Molecular Medicine, Medical University of Warsaw, Warsaw, Poland.

Roman Paduch (R)

Department of General Ophthalmology, Medical University of Lublin, Lublin, Poland.
Department of Virology and Immunology, Institute of Microbiology and Biotechnology, Maria Curie-Skłodowska University, Lublin, Poland.

Mirosław Łańcut (M)

Center for Experimental Medicine, Medical University of Lublin, Lublin, Poland.

Paweł Piwowarczyk (P)

2nd Department of Anesthesiology and Intensive Care Unit, Medical University of Lublin, Lublin, Poland.

Mirosław Czuczwar (M)

2nd Department of Anesthesiology and Intensive Care Unit, Medical University of Lublin, Lublin, Poland.

Robert Rejdak (R)

Department of General Ophthalmology, Medical University of Lublin, Lublin, Poland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH